GB0110797D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- GB0110797D0 GB0110797D0 GBGB0110797.8A GB0110797A GB0110797D0 GB 0110797 D0 GB0110797 D0 GB 0110797D0 GB 0110797 A GB0110797 A GB 0110797A GB 0110797 D0 GB0110797 D0 GB 0110797D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/93—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0110797.8A GB0110797D0 (en) | 2001-05-02 | 2001-05-02 | Chemical compounds |
| AU2002253350A AU2002253350A1 (en) | 2001-05-02 | 2002-05-02 | 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors |
| PCT/GB2002/002011 WO2002087587A2 (fr) | 2001-05-02 | 2002-05-02 | Amines bicycliques fusionnees |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0110797.8A GB0110797D0 (en) | 2001-05-02 | 2001-05-02 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0110797D0 true GB0110797D0 (en) | 2001-06-27 |
Family
ID=9913913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0110797.8A Ceased GB0110797D0 (en) | 2001-05-02 | 2001-05-02 | Chemical compounds |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002253350A1 (fr) |
| GB (1) | GB0110797D0 (fr) |
| WO (1) | WO2002087587A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE502928T1 (de) | 2000-11-01 | 2011-04-15 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
| EP1496907B1 (fr) * | 2002-04-12 | 2007-09-19 | Merck & Co., Inc. | Inhibiteurs de la tyrosine kinase |
| DE102007042154A1 (de) * | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| US20110098305A1 (en) * | 2008-05-21 | 2011-04-28 | Jonathan Bayldon Baell | Arylsulfonamide compounds, compositions and methods of use |
| CN106432215A (zh) * | 2016-08-09 | 2017-02-22 | 浙江医药高等专科学校 | 含噻吩磺酰胺结构的苯并喹唑啉类酪氨酸激酶抑制剂及用途 |
| CN106317037A (zh) * | 2016-08-09 | 2017-01-11 | 浙江医药高等专科学校 | 一种含噻吩磺酰胺结构的乙氧苯并喹唑啉类酪氨酸激酶抑制剂及用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2473931A (en) * | 1945-11-09 | 1949-06-21 | Merck & Co Inc | 2-and 4-sulfanilamido quinazoline |
| AT252922B (de) * | 1965-03-11 | 1967-03-10 | Biochemie Gmbh | Verfahren zur Herstellung von 2-alkoxysubstituierten 4-Sulfanilamido-chinazolinen |
| GB1092737A (en) * | 1965-06-02 | 1967-11-29 | Mead Johnson & Co | 2-methoxy-4-[n-glutarylsulfanilamido]quinazoline and process for preparing the same |
| US5710158A (en) * | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| GB9510757D0 (en) * | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| PT885198E (pt) * | 1996-03-05 | 2002-06-28 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina |
| GB0007657D0 (en) * | 2000-03-29 | 2000-05-17 | Celltech Therapeutics Ltd | Chemical compounds |
-
2001
- 2001-05-02 GB GBGB0110797.8A patent/GB0110797D0/en not_active Ceased
-
2002
- 2002-05-02 AU AU2002253350A patent/AU2002253350A1/en not_active Abandoned
- 2002-05-02 WO PCT/GB2002/002011 patent/WO2002087587A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002253350A1 (en) | 2002-11-11 |
| WO2002087587A2 (fr) | 2002-11-07 |
| WO2002087587A3 (fr) | 2003-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0115109D0 (en) | Chemical compounds | |
| GB0103926D0 (en) | Chemical compounds | |
| GB0103630D0 (en) | Chemical compounds | |
| GB0115393D0 (en) | Chemical compounds | |
| GB0107228D0 (en) | Chemical compounds | |
| GB0108046D0 (en) | Chemical compounds | |
| AU2002366440A8 (en) | Chemical compounds | |
| GB0114005D0 (en) | Chemical compounds | |
| GB0108793D0 (en) | Chemical compounds | |
| GB0108764D0 (en) | Chemical compounds | |
| GB0113231D0 (en) | Chemical compounds | |
| GB0106446D0 (en) | Chemical compounds | |
| GB0110797D0 (en) | Chemical compounds | |
| GB0101226D0 (en) | Chemical compounds | |
| GB0108594D0 (en) | Chemical compounds | |
| GB0104418D0 (en) | Chemical compounds | |
| GB0103629D0 (en) | Chemical compounds | |
| GB0106877D0 (en) | Chemical compounds | |
| GB0106871D0 (en) | Chemical compounds | |
| GB0108593D0 (en) | Chemical compounds | |
| GB0105077D0 (en) | Chemical Compounds | |
| GB0108654D0 (en) | Chemical compounds | |
| GB0115392D0 (en) | Chemical compounds | |
| GB0103990D0 (en) | Chemical compounds | |
| GB0109248D0 (en) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |